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ABSTRACT 
 
REDOX REGULATION OF HUMAN P53 TUMOR SUPPRESSOR 
GENE ACTIVITY: IDENTIFICATION OF REDOX GENES THAT 
PLAY ROLE IN HUMAN P53 REPORTER GENE ACTIVITY 
 
 
The occurence of p53 gene mutations in many human tumors shows that p53 
protein plays an important role in preventing cancers. One of the most important 
function of p53 protein is its ability to stimulate transcription of other genes that inhibit 
cell cycle progression and DNA repair mechanisms or apoptosis pathways. p53 gene 
activity is controlled by a series of mechanisms among which redox regulation has 
taken little attention. Because of its importance as a tumor suppressor, its role as a cell 
cycle control protein and transcription factor, we decided to focus on p53 transcriptional 
activity. Human p53 can be studied in yeast where genetic tools can be used to identify 
proteins that affect its ability to stimulate transcription of reporter genes. Several studies 
have shown that the p53 protein is prone to oxidative inactivation.  Although yeast does 
not contain a p53 gene, the similarity of cell cycle control mechanisms and oxidative 
stress response pathways prompted us to ask whether human p53 was active in yeast 
cells lacking individual antioxidant genes. In this study, using yeast deletion mutants, 
p53 reporter gene activity was assayed in different antioxidant mutants that were 
identified by REDOX-Cys-Search bioinformatic tool by previous studies. Seven 
antioxidant genes were found to be important in regulating p53 activity. These genes 
played role in phosphatidylinositol pathway, protein dephosphorylation, cellular iron 
metabolism, DNA mismatch repair,  and three other unknown biochemical pathways. 
Identification of these new proteins that regulate p53 activity may have broad 
implications in understanding the complex behaviour of p53 and tumor formation in 
humans. 
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ÖZ 
 
İNSAN P53 TÜMÖR BASKILAYICI GEN AKTİVİTESİNİN REDOX 
REGÜLASYONU: İNSAN P53 RAPORTÖR GEN AKTİVİTESİNDE  
ROL OYNAYAN REDOKS GENLERİNİN BELİRLENMESİ 
 
 
 İnsan tümörlerinin çoğunda p53 mutasyonlarının görülmesi bu proteinin kanser 
önlemede önemli rol oynadığını gösterir. p53 proteinin bir transkripsiyon faktörü olarak 
en önemli fonksiyonu, başka proteinleri aktive ederek hücre döngüsünün durmasını ve 
DNA tamiri veya kontrollü hücre ölümü yolaklarının aktive edilmesini sağlamasıdır. 
p53 aktivitesini kontrol eden birçok mekanizma bilinmesine rağmen redoks kontrol 
mekanizması fazla çalışılmamıştır. Tümör süpressör olarak büyük öneme sahip olması 
ve hücre döngüsünün kontrolünde önemli roller üstlenmesi nedeni ile bu projede p53 
proteinin redoks regülasyonunu çalışmak istedik. İnsan p53’ü, mayada raportör genlerin 
transkripsiyonunu uyaran proteinleri belirleyen genetik araçların kullanılmasıyla 
çalışılabilir.  Bazı çalışmalar p53 proteininin oksidatif inaktivasyona yatkın olduğunu 
göstermiştir. Mayada p53 geni bulunmamasına rağmen benzer hücre döngüsü kontrol 
mekanizmaları ve oksidatif stres yanıt yolakları bizi insan p53’ünü ayrı antioksidan 
genleri eksik olan maya hücrelerinde aktif olup olmadığını sorgulamaya yöneltti. 
Yaptığımız ön çalışmalar ile maya hücrelerinde bulunan bütün antioksidan genler, 
yapılarında bulunan bazı ayırt edici karakterler sayesinde REDOXCysSearch olarak 
bilinen biyoinformatik programının yardımı ile tespit edildi. Bu çalışmada antioksidan 
genlerin delesyon mutantları kullanılarak insan p53 raportör gen aktivitesini etkileyen 
antioksidant genler tespit edildi. Bu genler biyokimyasal olarak fosfotidil inositol, 
protein defosforilasyonu, hücresel demir metabolizması, DNA yanlış eşleşme tamiri 
(mismatch repair) yolaklarında ve üç ayrı bilinmeyen yolakta daha rol oynamaktadır. 
p53 aktivitesini düzenleyen yeni proteinlerin belirlenmesinin geniş uygulama alanları 
olacaktır. p53’ün redoks regülasyonu transkripsiyon faktörü olarak aktivitesinin 
kontrolü açısından yeni bir örnek teşkil edecektir. 
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CHAPTER 1 
 
INTRODUCTION 
1.1. p53 Protein 
 
p53 is one of the most important tumor suppressor proteins. It is shown to be 
mutated in more than 50% of the tumor cells. p53 protein is discovered firstly in SV40 
tumor virus containing tissues in high levels and defined as a tumor antigen in 1979 
(Lane and Crawford 1979, Linzer and Levne 1979). p53 is found in low levels in a 
normal cell; however under cellular stress conditions like DNA damage, hypoxia, dNTP 
shortage and absence of telomerase activity, it is shown to be one of the most induced 
proteins (Vousden and Lu 2002). These stress conditions stabilizes and activates p53 
that causes cause cell cycle arrest and activates repair mechanisms. However, if the 
damage can not be repaired, apoptosis is initiated. There are more than 100 genes 
determined as activated or inhibited by p53 as a transcription factor. According to 
bioinformatic studies there are more than 4000 potential p53 binding sites in genome 
(Vousden and Lu 2002). These studies enlighten the importance of p53. 
 
1.2. p53 Structure 
 
p53 protein has five domains including transactivation, proline rich, DNA-
binding, tetramerization and negative regulation domains (Figure 1.1).  This protein 
performs as a tetramer by binding to DNA sequence specifically (Figure 1.2).  95% of 
the p53 mutations shown to be in the DNA binding domain resulted with the loss of 
DNA binding ability of the protein (Vousden and Lu 2002). DNA binding ability of p53 
can also be affected by the redox state of cystein residues in the protein especially in its 
DNA binding domain. Intermolecular or intramolecular extra disulfate bridges could 
prevent the molecule from binding to DNA (Pearson and Merill 1997).  
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Figure 1.1. Domains of p53 protein and location of the cyctein residues in DNA-binding domain 
(Source: p53.free.fr) 
 
Figure 1.2. p53 tetramere bound to DNA  
(Source: Joerger and Fersht 2008) 
 
1.3. Regulation of p53 
 
In addition to known effects of mutations to p53 structure and activity can be 
altered transcriptionally, translationally, post-translationally or by controlling its 
function independent from its expression.  
Regulation of p53 at transcriptional level was shown by inductive effect of 
interferon α/β in 2003 (Takaoka, et al. 2003). At translational level, RNA binding HuR 
protein is shown to increase the p53 expression (Mazan-Mamczarz, et al. 2003, Galban, 
et al. 2003).  
C176 C182 C242 C277 C229 
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Post-transcriptionally p53 level is hold in low levels mainly by Mdm2 under 
normal conditions. Mdm2 has E3 ubiquitin ligase activity. It has ability to bind to p53 
and to mark it for proteozomal degradation (Honda, et al. 1998). Mdm2 is 
transcriptionally induced by p53, thus p53 controls the cellular level of itself by 
negative feed back (Momand, et al.  2000). DNA damage and stress signals inhibit the 
interaction between Mdm2 and p53 then increase the stability and cellular level of p53. 
In this way p53 can bind to specific sequences to activate specific genes of interest 
(Kaustov, et al.  2006). In some tumors, the increased level of proto-onco gene Mdm2 
inactivates p53 without any mutation. (Momand et al. 2000). While the transcription 
factor YY1 increrases Mdm2 originated p53 degradation (Gronroos, et al. 2004, Sui, et 
al. 2004), AbI, p14ARF, L11, PML and Rb proteins decrease (Hsieh, et al.  1999, 
Lohrum, et al. 2003, Bhat, et al. 2004, Zhang, et al.  2003). Except that Mdm2, other E3 
ubiquitin ligases like Pirh2, COP1, CHIP and ARF-BP1 proteins take part in regulation 
of p53 levels by protein-protein interaction.  (Leng, et al. 2003, Dornan, et al. 2004, 
Esser, et al. 2005, Chen, et al. 2005).  
There are numerous post-transcriptional covalent modifications that p53 can 
encounter. Phosphorylation, acetylation, methylation, ubiquitination, sumoylation, 
glycosylation and neddylation are those identified while some of them stabilizing, 
destabilizing or both (Chuikov, et al. 2004, Xirodimas, et al. 2004) (Figure 1.3). Other 
than covalent modifications, there are some molecules which regulate the activity of 
p53 by non-covalent interactions.  
Phosphorylation sites of p53 are shown to be serine and threonine residues found 
in 17 different positions. (Xu 2003, Bode and Dong 2004). There are different effects of 
p53 phosphorylation. The effect of modification differs as stabilizing or destabilizing 
depend on the residue that was phosphorylated. (Katayama, et al. 2004, Li, et al. 2004). 
Different kinases are determined to phosphorylate different residues and more than one 
site could be phosphorylated at the same time. This situation is thought to be related 
with different responses to different stimulants. (Xu 2003; Bode and Dong 2004). 
However, phosphorylation of p53 does not known to increase the DNA binding ability 
in vivo. (Feng, et al. 2005).  
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Figure 1.3. p53 modifications in response to cellular stres  
(Source: Lu 2005) 
 
The methylation, acetylation and sumoylation of p53 is shown to make the 
molecule stable and increase its transactivation and DNA binding ability (Chuikov, et 
al. 2004, Luo, et al. 2004; Lu 2005). Methylation of p53 ensures the molecule to stay in 
the nucleus and increase its transcriptional ability. In case of DNA damage, p53 is 
shown to be methylated at the 372th lysine residue by a methyl transferase Set9 both in 
vitro and in vivo. (Chuikov, et al. 2004). p53 activating enzyme p300/CBP acts as an co-
activator by histon acetylation. (Liu, et al. 2003). Other studies show that p300/CBP 
also acetylates p53 at the carboxy terminal and could affect its DNA binding ability 
(Luo, et al. 2004). SUMO-1 binds to transcription factors like p53 and increases its 
transcriptional activity. Mechanism of the increased activity as a result of the 
sumoylation at 386th lysine residue is not known. The cross-interaction between 
acetylation and sumoylation which occurs both at the carboxy terminal does not 
identified (Liu and Chen 2006). 
Deacetylation, ubiquitination and neddylation are known to decrease the stability 
and transcriptional activity of p53. By deacetylating the acetylated p53, histone 
deacetilase (HDAC) 1, 2 and 3 are shown to decrease its transcriptional activity (Juan, 
et al. 2000; Insinga, et al. 2004). HDAC does not interact directly with p53. Metastasis 
associated protein 2 (MTA2)/PID, Sir2α and PML-retionic acid receptor (RAR) are 
found to take part to repress p53 by histon deasetylases. (Luo, et al. 2000, Luo, et al. 
2001, Insinga, et al. 2004).  
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Ubiquitination is a pathway used for selectively degrading cellular proteins.  
Addition of ubiquitin molecules covalently to proteins marks them for proteozomal 
degradation. (Hershko and Ciechanover 1998). While mono-ubiquitination of p53 is the 
signal to exit the nucleus, poly-ubiqutination is the signal for its proteozomal 
degradation by 26S proteosome. For normal progress of cell cycle p53 levels should be 
regulated thightly which mainly controlled by ubiquitination of p53 by Mdm2. (Li, et al. 
2003, Yang, et al. 2004). Mdm2 can both mono ubiqutinate and by the help of p300, 
poly-ubiquitinate p53 (Grossman, et al. 2003). The ubiquitination of p53 by both Mdm2 
and other E3 ubiquitin ligases is shown to be recycling. Herpes virus associated 
ubiquitin specific protease (HAUSP) is shown to stabilize p53 both in vitro and in vivo. 
However the effect of HAUSP is not understood completely. (Li, et al. 2002).  
NEDD8 is an ubiquitin like molecule is also named as Rub1 or Apg12. 
Neddylation of p53 is promoted by Mdm2 similar to its ubiquitination and the process is 
resulted with the loss of transcriptional activity (Xirodimas, et al. 2004). 
There are some other molecules regulating p53 activity like Ref-1. (Liu and Chen 
2006). Regulating the redox state of some proteins and acting as a DNA repair 
endonuclease are its two distinct functions of Ref-1. It is shown to induce the DNA 
binding ability of p53 independent of its carboxy terminal when oxidized or dependent 
when reduced (Gaiddon, et al. 1999). Moreover, selenomethyonine which has anti-
cancer properties requires Ref-1 in redox mechanism to activate p53 (Seo, et al. 2002). 
In contrast to other known modifications, redox regulation of p53 is not quite studied. 
Consequently, I want to study redox regulation of p53 to understand the influence of 
anti-oxidant genes on one of the most important tumor supressor protein. 
 
1.4. Previous p53 Studies with Yeast 
 
Yeast is a preferable model organism to take advantage of genetic studies. It is 
also used in some p53 studies. Although yeast does not have p53 gene there are similar 
cell cycle control mechanisims with human. The role of PAK1 and TRR1 genes are 
identified by this way. p53 activating kinase (PAK1) over-expressing Saccharomyces 
cerevisiae strains are showed increased DNA binding capasity. Increased transactivation 
of p53 is thought to be originated from phosphorylation by PAK1 from its carboxy 
terminal. (Thiagalingam, et al. 1995). In 1998, it is found that in the absence S. 
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cerevisiae thioredoxin reductase coding gene, the DNA-binding activity of p53 is 
diminished (Pearson and Merrill 1998). This effect is understood by the reduced 
expression of the reporter gene coded after multiple p53 binding sites. This binding site 
is determined as RRRC(A/T)GYYY by oligonucleotide selection experiments (Funk, et 
al. 1992). The ectopic expression of disulphate bridge reducing TRR1 gene in TRR1 
mutant yeast strain recovered p53 activity (Pearson and Merrill 1998). TRR1 studies 
suggest that the inhibition of p53 activity is caused by the reduced cycteins of directly 
p53 or indirectly other related proteins as a result of thiol oxidation (Merrill, et al. 1999, 
Merwin, et al. 2002).  In the light of the literature, I want to explore the effects of the 
known and potential redox proteins of S. cerevisiae on p53 by deletion mutants of those 
genes in this study. 
 
1.5. Yeast Anti-oxidant Genes 
 
Main mechanisms that regulate protein activity are kinase/phosphotases and thiol 
dependent oxido-reductases. There are mainly two redox mechanisims which are 
thioredoxin and glutathione systems. Both systems transfer the electrons of NADPH to 
their target molecule (Holmgren 2000). These type of proteins include a beta-sheet at 
the center surrounded by alfa-helices with one or two cycteins at the active site which is 
called thioredoxin-fold motif (Martin 1995). Cysteins have important redox functions in 
protein activity by controlling reversible oxidation and reduction reactions.  Most 
studied redox motif is CXXC as two cycteins are separated by two other residues. 
Recent studies suggest that CXXS, TXXC, CXXT, SXXC motifs also provide redox 
activity (Fomenko and Gladyshev, 2003). Other amino acids located on both sites of 
these motifs and secondary structures determines the function of these proteins 
(Woycechowsky and Raines, 2000).  
Bioinformatic studies enable us to study these antioxidant genes genome-wide 
instead of searching in single gene level. All oxido-reductive proteins can be determined 
in organisms those gemome was sequenced by using bioinformatic algorithms 
(Fomenko and Gladyshev, 2002, Fomenko and Gladyshev, 2003, Fomenko, et al. 2007).  
The list of potential and known redox proteins in S. cerevisiae was composed by the 
help of Dr. Fomenko previously (Table-1). The software used for this study can be 
found in its web site (Genomics, 2008). The algorithm that REDOXCysSearch software 
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followed is given in Figure 1.4. The obtained protein sequences of yeast in FASTA 
format are searched for containing the specific motifs which are CXXS, TXXC, CXXT 
and SXXC. Metal binding proteins are eliminated from the selected ones as these motifs 
are also capable of binding metal ions. The remaining proteins are analysed for 
conservation through other species. If the candidate protein is conserved then secondary 
structure prediction is made to determine the compatibility of the motif with 
thioredoxin-fold motif. The selected proteins are analysed individually for their 
structural and biochemical properties and as a result 88 known and potential yeast 
proteins are selected as anti-oxidant (Fomenko and Gladyshev 2002, 2003, Fomenko et 
al, 2007).  
 
 
Figure 1.4. Schematic representation of the algorithm for identification of thiol/disulfide oxidoreductases 
(Fomenko and Gladyshev 2002, 2003, Fomenko et al, 2007) 
 
The yeast deletion mutants selected according to the REDOXCysSearch results 
are listed in Table-1 and they were obtained from EUROSCARF organization 
commertially (Euroscarf, 2000). All the deletion mutants in this table will be analysed 
for p53 gene activity to enlighten the roles of antioxidant genes in the regulation of p53.  
 
Table 1.1. Redox active yeast genes 
gi number Protein 
length 
CxxC 
position 
Secondary 
structure 
Description  
6319806 522 60 
405 
b-CGHC-a 
b-CGHC-a 
protein disulfide isomerase; Pdi1p 
6319814 110 26 b-CPYC-a Glutaredoxin; Grx1p 
Protein  sequences in FASTA format  
Identification of proteins containing CXXC 
Filtering out metal binding proteins 
Analysis of conservation profile of CXXC 
Secondary structure prediction  
Individual analysis of candidate redox proteins  
88 anti-oxidant genes  
 
(cont. on next page) 
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6319925 127 54 b-CGPC-a Mitochondrial thioredoxin; Trx3p 
6320492 114 30 b-CGLC-a thioredoxin (COG) 
6320720 143 60 b-CPYC-a Glutaredoxin 
6681846 189 29 
129 
CRSC-a 
a-CNWC-a 
Protein essential for mitochondrial 
biogenesis and cell viability; Erv1p 
6321648 104 30 b-CGPC-a thioredoxin; Trx2p 
6322186 701 59 
199 
b-CPHC-a 
b-CDKC-a 
Thiol-disulfide isomerase 
6322811 256 195 b-CTSC-a Nifu-like protein; Nfu1p 
6323072 103 29 b-CGPC-a thioredoxin; 
6323396 109 24 b-CPDC-a Glutaredoxin (COG- thioredoxin) 
6323505 561 348 
351 
a-CVQC-a 
a-CDRC-a 
involved in protein disulfide bond 
formation in the ER; Ero1p 
6324484 277 55 b-CQHC-a Thiol-disulfide isomerase 
(thioredoxin?????) 
6324862 318 58 b-CGHC-a Thiol-disulfide isomerase 
(thioredoxin?????) 
12621477 82 46 CPSC-a Similar to Hemiascomycetous yeast 
protein 
6320163 562 371 b-CVTC-a regulator of silencing at HML, HMR, 
telomeres, and rDNA; Sir2p 
6320169 114 38 a-CNSC- Hypothetical ORF; Ydl034wp 
6320293 382 121 a-CRNC-a splice site choices and 2nd step of 
splicing; Slu7p 
6321227 193 21 a-CELC-a Predicted ATPase of the PP-loop 
superfamily implicated in cell cycle 
control (COG) 
6322432 111 52 a-CFAC-a peroxisome proliferator-activated 
receptor 
6322474 198 7 -CGIC-a Translation initiation factor (SUI1) 
(COG) 
6322548 954 71 
207 
b-CCYC-a 
-CIYC- 
inhibitor of apoptosis protein 
6322637 623 391 b-CMDC-a integral membrane protein localizing 
to the ER and Golgi 
6323301 274 247 b-CFFC-a Hypothetical protein Ylr271wp 
6323600 280 243 
255 
b-CSIC-a 
-CVNC-a 
Hypothetical protein 
6323622 332 77 b-CQLC-a Putative new 37kDa subunit of N-
oligosaccharyltransferase complex; 
Ost6p 
6323747 620 529 a-CRRC-a Homolog of samB gene of 
Aspergillus nidulans (deletion of 
samB results in mislocalization of 
septa 
6324005 879 4666 b-CIDC-a FIG4 expression is induced by 
mating factor.; 
6324209 493 2 
365 
CQRC-a 
b-CQIC-a 
Predicted ATPase of the PP-loop 
superfamily implicated in cell cycle 
control (COG) 
6324224 1183 445 b-CLDC-a Synaptojanin-like protein 
6324311 112 23 a-CEKC-a Hypothetical protein 
6324504 503 317 b-CVTC-a Homolog of SIR2 
6324659 350 72 b-CSLC-a Catalyzes the transfer of 
oligosaccharide from dolichol-
oligosaccharide donor to 
consensusglycosylation acceptor sites 
(asparagines) in newly synth. 
proteins - ER lumen; may enhance 
(cont. on next page) 
Table 1.1 (cont.) 
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oligosacch. transfer to subset of 
acceptor substrates 
6324683 1107 420 b-CLDC-a Synaptojanin-like protein 
6324770 414 184 b-CRFC-a Lipoate synthase (COG) 
6324832 217 187 CCYC-a histidine triad superfamily, third 
branch; 
6324848 428 374 a-CNVC-a RNA isopentenyl transferase 
6325150 248 90 -CVNC-a Hypothetical protein 
6325296 196 120 a-CGEC-a homologous to ERV1; Erv2p 
6319647 580 144 
215 
-CEYC- 
-CSKC- 
Nuclear pore or nuclear pore-
associated protein required for 
nuclear membrane integrity and 
nuclear transport 
6320126 1049 984 -CPIC- Required for the vacuolar 
morphogenesis in yeast 
6320667 374 130 -CSEC- Hypothetical protein 
6324347 270 130 -CDYC- Hypothetical protein 
6321419 278 183 -CPSC- beta (38kDa) subunit of casein kinase 
II (CKII) 
6321421 503 19 -CGYC- arginyl-tRNA-protein transferase 
6321725 375 102 -CKYC- Biotin synthase 
6321824 630 47 -CLFC- Hypothetical ORF 
6321882 282 264 -CPEC- Yeast homolog of mammalian Ing1 
6322217 364 306 -CPGC- nitrogen starvation-induced protein 
phosphatase 
6323273 387 36 -CPVC- methionine aminopeptidase 
6323933 732 125 -CTQC- TFIIF interacting Component of 
CTD Phosphatase 
6324552 1001 51 -CTKC- Possible component of RCC1-Ran 
pathway 
6324613 258 166 -CPSC- Casein kinase II, beta' subunit 
6324911 958 187 -CGPC- Cytoplasmic alanyl-tRNA synthetase 
6325171 557 117 -CVYC- elongator protein; histone and other 
protein acetyltransferase; has 
sequence homology to known HATs 
and NATs 
6325439 768 79 -CPIC- cytoplasmic GTPase-activating 
protein 
6226540 251 221 -SELC- subunit II of cytochrome c oxidase 
SxxC motif including proteins 
6323138 176 58 b-SPTC-a Ahp1 alkyl hydroperoxide reductase 
6320661 196 44 b- SFVC-a Tsa2 
6324090 483 93 SGRC-a aminopeptidase of cysteine protease 
family 
6321488 107 64 SAPC-a Hypothetical ORF 
14318479 375 13 -SGMC- Involved in cell polarization, 
endocytosis and other cytoskeletal 
functions 
CxxS motif including proteins 
6319488 203 108 -CPYS- Glutaredoxin 
6320193 231 136 -CSYS- Glutaredoxin 
6320303 285 211 -CGFS- Glutaredoxin 
6321022 244 171 -CGFS- Glutaredoxin 
6325198 150 60 -CGFS- Glutaredoxin 
6320726 517 62 
405 
-CLHS- 
-CIHS- 
Protein thiol-disulfide isomerase, 
ER-resident protein 
6321642 148 90 -CMLS- Required for arsenate resistance 
6325458 130 76 -CTGS- Required for arsenate resistance 
(cont. on next page) 
Table 1.1 (cont.) 
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6320882 449 198 CRES- S-adenosyl-L-homocysteine 
hydrolase 
6324041 373 181 -CVAS- Hypothetical ORF; Caf40p 
6324588 757 583 -CISS- B-type regulatory subunit of protein 
phosphatase 2A 
6320878 72 24 -CASS Hypothetical ORF; Yer039c-ap 
6321792 472 3 CTVS- Component of pheromone response 
pathway 
6319497 1165 448 CIAS- Required for chitin synthesis 
6321005 801 565 -CIVS- Secretion (golgi retention) deficient 
6322745 717 405 -CGTS- Required for biosynthesis of cell wall 
6322811 256 199 -CSSS- NifU-like protein 
6324247 904 848 -CRSS- Required for mismatch repair in 
mitosis and meiosis 
6325025 1887 1305 CATS- Trifunctional enzyme 
6319816 168 157 -CVNS- Methionine-Rsulfoxide reductase 
14318476 674 239 -CFNS- Hypothetical ORF 
6323001 250 244 -CGES- HesB-like protein 
6324521 396 284 -CGYS- S-adenosylmethionine decarboxylase 
6325324 185 177 -CGSS- HesB-like protein 
     
CxxT motif including proteins 
6319721 162  36 b- CGFT-a Glutathione peroxidase paralogue; 
Gpx2p 
6321593 356 30 b- CPFT-a glutathione S-transferase 
6321876 688 143 a- CLKT-a Involved in pheromone and 
pseudohyphal growth signal 
transduction 
6322228 163 35 b- CGFT-a Hydroperoxide resistance conferring 
gene; Hyr1p 
6322826 167 35 b- CAFT-a Glutathione peroxidase paralogue; 
Gpx1p 
6323871 524 253 b- CSGT-a Glycolipid anchored surface protein 
6324049 438 381 a- CLAT-a sterol C-14 reductase; Erg24p 
6324082 767 62 b- CGPT-a Protein required for cell viability; 
Ynl247wp 
TxxC motif including proteins 
6319407 261 87 b- TPVC-a mPrx Peroxiredoxin 
6322180 215 103 b- TPGC-a Derepression Of Telomeric silencing; 
Dot5p 
6319726 370 340 b- TDAC-a 3-deoxy-D-arabino-heptulosonate 7-
phosphate synthase 
6323067 83 23 - TKHC-a essential during assembly for full 
cytochrome c oxidase activity 
6323613 196 44 b- TFVC-a antioxidant enzyme that provides 
protection against oxidation systems 
capable of generating reactive 
oxygen and sulfur species; Tsa1p 
6324800 156 84 b- TFGC-a Iron-sulfur cluster nifU-like protein; 
Isu2p 
6325122 165 92 b- TFGC-a Iron-sulfur cluster nifU-like protein; 
Isu1p 
 
 
 
Table 1.1 (cont.) 
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CHAPTER 2 
 
MATERIALS AND METHODS 
2.1. Plasmids 
 
pRS315 and pRS316 plasmids used in this study are shuttle vectors which can 
replicate both in bacteria and yeast. Escherichia coli was used to replicate these 
plasmids in high amount. These plasmids are centromeric and found in 1-3 copy 
numbers in yeast cells.  
pRS316 plasmid carries highly strong yeast promoter PGK followed by human 
TP53 gene coding for p53 which is terminated with a yeast terminator. URA3 gene is 
the selection marker gene of the plasmid (Figure 2.1). 
 
Figure 2.1. pRS316 PGK p53 plasmid 
 
pRS315 plasmid carries p53 universal DNA binding site “Response Element” 
(RE) followed by Lac-Z gene coding for β-galactosidase enzyme. LEU2 gene is the 
selection marker gene of the plasmid (Figure 2.2). 
pRS316 PGK p53
URA3 ampR 
f1 ori 
pMB1 ori 
CEN6
ARSH4
PGK promoter 
TP53
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Figure 2.2. pRS315 RE-Z plasmid 
 
In case of transformation of both plasmids to yeast, we expect that the expressed 
p53 protein bind to RE and induce the expression of β-galactosidase enzyme which is 
the reporter protein, if the p53 protein is functional and has the DNA binding ability. 
The system was tested initially with X-gal which is a substrate of β-galactosidase. 
Wild type strain is transformed with both plasmids, pRS315 RE-Z only and pRS316 
PGKp53 only. Cells were grown and simply disturbed with glass beads. The β-
galactosidase activity of the double transformed cells was compared with non-
transformed and single transformed cells. 
 
2.2. Yeast transformation with Li-Ac method 
 
BY4741 (MATα, ∆his3, ∆ura3, ∆met15, ∆leu2) is the wild type strain used as 
control to compare the p53 activity with deletion mutants. All deletion mutants were 
derived from this strain. 
Transformation of yeast strains was achieved by lithium acetate method (Amberg, 
et al. 2005). Strains steaked on YPD agar plate overnight. Grown cultures harvested by 
pRS315 RE-Z
LEU2 ampR 
f1 ori 
pMB1 ori 
CEN6
ARSH4
p53 universal      
DNA binding 
site (RE) LacZ
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a loop and washed with sterile dH2O. Cells centrifuged in top speed for 5sec to pellet 
the cells. Pellet is resuspended in 0,1M Li-Ac and pelleted by the same process. The 
pellet then resuspended in 240 µl 50% PEG, 36 µl 1M Li-Ac, 5 µl salmon sperm single 
stranded carrier DNA (10mg/ml) 5 µl pRS316 PGK p53 plasmid, 5 µl pRS315RE-Z 
plasmid and 69 µl sterile dH2O respectively. Suspention was vortexed vigorously and 
incubated for 30min at 30°C then heat shocked at 42°C for 20-25min. Transformed cells 
were spreaded on synthetic agar media (YNB) including methionine and histidine but 
without uracil and leucine (YNB-leu-ura). Colonies were allowed to grow for 2-3 days. 
The transformation protocol was applied to 88 redox mutants.  
 
2.3. B-galactosidaside assay 
 
At least three transformed colonies taken by a loop and spreaded on a YNB -leu-
ura agar plate to allow them to grow. Grown cells were inoculated in 5ml YNB -leu-ura 
liquid media for 24 hours. Optical density (OD) of cultures were diluted to 0,1 in 10ml 
YNB -leu-ura media according to absorbance value at 600nm. Cells were allowed to 
grow for at least 4 hours to ensure that they are in logarithmic growth phase. Between 
0,2 and 0,5 OD values at 600nm 100 µl of culture is taken and freezed in -80 °C.  
Frozen cultures were defrost in 100 µl YNB -leu-ura media and 400 µl Z-buffer 
which includes 60mM Na2HPO4, 40mM NaH2PO4, 10mM KCl, 1mM MgSO4, 50mM 
β-mercaptoethanol and 0,2% L-Lauryl Sarcosine. After 30min preincubation at 30°C, 
150 µl Z-buffer with 4mg/ml ONPG was added to suspensions and the mixtures were 
incubated in 30 °C for 30min. The reaction is stopped by adding 400 µl 1.5M Na2CO3. 
The mixture was pelleted at top speed for 1 min and the supernatant is used for the 
measurement at 420nm (Kippert 1995). 
The absorbance values were normalized according to their OD values and 
compared to the absorbance values of the wild type strain. 
 
2.4. Determination of oxidative stress tolerance 
 
Selected yeast mutants are tested for their oxidative stress tolerance. Two different 
agents are used to induce oxidative stress on cells which are H2O2 and diamide. H2O2 is 
a natural by-product of oxygen metabolism and substrate of peroxidases which is 
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decomposed to H2O and oxygen. Diamide is a sulfhydryl-oxidizing agent, which can 
interact with the cystein residues of proteins and as a result cause denaturation (Eaton 
2005).  
Halo assay was used to test its effect on mutant strains. Cells were grown 
overnight and diluted to 0.2 at OD600. Approximately 50.106 were spreaded on YPD 
plate 30 min before 5µl 8.8M (%30) H2O2 was pipetted at the center. The plates were 
incubated for 2 days and the diameter of the hole at the center of the plate without 
growth was measured to indicate the H2O2 sensitivity of the strains in compared to wild 
type. 
Strains were grown overnight and diluted to 0.2 at OD600. A set of dilution series 
were prepared: 2.10-1, 2.10-2, 2.10-3 and 2.10-4. 5µl from each dilution is dropped on 
YPD plates containing no diamide, 0.5mM, 1mM, 1.5mM and 2mM diamide. Plates 
were incubated for 2 days to observe the sensitivity difference among each other. 
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CHAPTER 3 
 
RESULTS 
The initial testing of the plasmid system gave positive result to X-gal in double 
transformed cells wild type cells while negative in non-transformed and single 
transformed cells as expected (Figure 3.1). Thus we proceed to the transformation of 
mutant strains.  
 
Figure 3.1. Testing of plasmids and experimental design by X-gal 
 
 
3.1. B-galactosidaside assay  
 
After transformation and β-galactosidase assay of 88 mutant strains in three 
replicates, 19 of them were selected for the second and third repeats of the experiment. 
They were transformed all over again and grown for β-galactosidase assay. As a result, 
7 of the deletion mutants were selected for decreased p53 activity 2 to 13 fold according 
to the reporter gene activity of the wild type (Figure 3.2). These are SAC1, PMS1, 
RTS1, NFU1, HNT3, YDR286C and YHR035W.  
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YDR286C and YHR035W are uncharacterized open reading frames (Giaever, et al. 
2002). SAC1 is known as lipid phosphoinositide phosphatase of the ER and Golgi (Guo, 
et al. 1999). PMS1 is determined as an ATP-binding protein required for DNA mismatch 
repair in mitosis and meiosis (Prolla, et al. 1994). RTS1 is the B-type regulatory subunit 
of protein phosphatase 2A (PP2A) and also homolog of the mammalian B' subunit of 
PP2A (Giaever, et al. 2002). NFU1 is a protein involved in iron metabolism in 
mitochondria (Giaever, et al. 2002). HNT3 is the member of the third branch of the 
histidine triad (HIT) superfamily of nucleotide-binding proteins however its molecular 
function is not determined yet (Huttenhower and Troyanskaya 2008).  
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Figure 3.2. β-galactosidase assay results 
 
 
3.2. Oxidative stress tolerance 
 
The mutants showing decreased p53 activity were analysed for further 
characterization. Their oxidative stress tolerance were measured compared to wild type. 
Two different stress agents were used to understand whether they are more sensitive or 
not than wild type. Halo assay results showed that all mutants were 15% to 50% more 
sensitive to H2O2 than wild type (Figure 3.3).  
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Figure 3.3. Halo assay results 
 
Spotting assay results for diamide showed different sensitivity levels of mutants  
in compared to wild type (Figure 3.4). 0.5mM and 1mM diamide concentrations did  not 
show any effect on mutants. 1.5mM diamide showed that the most sensitive mutant for 
diamide effect is SAC1 mutant. The other mutants and wild type showed almost no 
sensitivity. However, on 2mM diamide, almost all strains showed growth defect. 
According to the results, YDR286C and NFU1 mutants were less sensitive to the effect 
of diamide than the wild type. 
 
 
Figure 3.4. Spotting assay results 
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CHAPTER 4 
 
DISCUSSION 
B-galactosidase assay results showed that absence of some of the anti-oxidant 
proteins can decrease p53 transactivation activity. These results neither reflect the 
mechanism of the inactivation nor the inactivation is redox dependent. 
Five of the seven genes express an identified protein. Two of them are open reading 
frames of unknown function. All of the seven genes have human homologs. Identified 
five proteins have similar function in humans. Unidentified YDR286C gene homolog in 
human codes for a glutaredoxin-like protein, while YHR035W gene homolog in human 
codes for a transport protein. One of the seven genes is denoted as anti-oxidant gene 
(YDR286C) while others have known or predicted distinct functions. Many proteins have 
more than one function. Therefore, these proteins might also have oxido-reductive effects 
on other proteins. However, what we do not know is, if their effect on p53 transactivation 
activity is redox dependent or not, or a result of distruption of the protein-protein 
interactions or any other type of regulations. The absence of these genes might interrupt 
the interaction of an upstream protein in a pathway which might resulted with decreased 
p53 activity. On the other hand, by using yeast as the model organism instead of a human 
cell, we minimize the interactions of regulatory proteins with the expressed p53. The 
other possibility is the interaction of the proteins of interest with p53 might be resulted 
with a known post-translational modification other than redox regulation. As mentioned 
before, two of the seven genes were known as phosphatases. Therefore the activity loss of 
p53 might be corelated with a phosphorylation/dephosphorylation process of p53 or the 
related proteins. 
Moreover, the oxidative stress tolerance tests cleared that stress agents show their 
effect in different ways as their results are not correlated. Especially, effect of diamide on 
mutants is interesting because instead of being more sensitive two of them (YDR286C 
and NFU1) were appearently less sensitive than wild type to sulfhydryl-oxidization. 
While we expect oxidation of cystein residues during redox regulation of p53, these two 
mutants are less prone to redox dependent activity loss of p53.  
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In contrast to these speculations, there is also the possibility of direct interaction 
and redox regulation p53 by the subjected proteins. So, we need to do further 
investigation to understand the reason of decreased transactivation activity.  
Complementation of the mutant genes should be the first step to observe whether 
p53 activity is restored or not, to confirm the results.  Then Cys → Ser point mutations 
can be introduced to both anti-oxidant genes and p53. Serine is the most similar amino 
acid to cysteine, it has an –OH group instead of a –SH group in its side chain. Introducing 
serine instead of cysteine in key points like DNA binding domain of the p53 would 
eliminate an oxidation side on the protein and the protein as a result could store its 3D 
structure or its active side.  These modifications on necessary genes will enable us to 
enlighten the relationship between p53 and the selected anti-oxidant genes so we can  
understand whether p53 activity decrease in mutants is purely redox dependent or not.  
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CHAPTER 5 
 
CONCLUSION 
In conclusion, 88 anti-oxidant gene mutants of yeast were analyzed for the p53 
transactivation activity and seven mutants were shown to have 2- to 13-fold decrease in 
p53 activity compared to the wild type. These mutants were analyzed for oxidative 
stress tolerance using diamide and H2O2. They were shown to be all sensitive to H2O2, 
however two of them were less sensitive to diamide than wild type. Mutants were 
experiencing intrinsic oxidative stress which may have resulted in oxidation and 
inhibition of p53 or the related proteins. The less affected two mutants from diamide are 
less prone to affect p53 activity in a redox dependent manner. 
To understand the reason of decreased transactivation activity of p53, 
complementation of deletion mutants will be achieved. As a result of complementation, 
we expect the mutant strains to restore their p53 activity. For further investigations, Cys 
→ Ser point mutations can be made by site-directed mutagenesis to understand the 
inactivation of p53 is whether related with oxidation or not. 
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